Physician profile
Fallon Crews
NPI 1003099052
$874.32
in general payments reported to CMS, 2019-2025
13 companies · $316 in 2025
The $316 reported for 2025 was more than what 86% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.00 · 2023: $114 · 2024: $424 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784 · Education: $70.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.60 |
| Education | $70.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.93 | 2023-2025 | |
| Ucb, INC. | $153.84 | 2023-2025 | Fintepla |
| Catalyst Pharmaceuticals, INC. | $88.26 | 2024 | |
| Jazz Pharmaceuticals INC. | $74.21 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $54.73 | 2024 | Daybue |
| Medtronic, INC. | $54.00 | 2024 | Percept Pc Brainsense |
| Biocodex, INC. | $39.09 | 2025 | |
| Neurelis, INC. | $35.04 | 2024-2025 | Valtoco |
| Boston Scientific Corporation | $31.64 | 2024 | |
| Merz Pharmaceuticals, LLC | $26.00 | 2024 | Xeomin |
| Azurity Pharmaceuticals, INC. | $21.13 | 2024 | Zonisade |
| Ns Pharma, INC. | $20.00 | 2022 | |
| Genentech USA, INC. | $19.45 | 2024 | Evrysdi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fallon Crews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.